Randy Lasut
Family · New Paris, PANPI 1063282994
Payments from drug & device makers
Across 145 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$267
- Novo Nordisk$251
- GSK$199
- Pfizer$196
- AstraZeneca$192
- Lilly USA, LLC$177
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,531100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $267 |
| Novo Nordisk | 16 | $251 |
| GSK | 13 | $199 |
| Pfizer | 12 | $196 |
| AstraZeneca | 9 | $192 |
| Lilly USA, LLC | 11 | $177 |
| Exact Sciences | 8 | $129 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| Ardelyx, Inc. | 4 | $93 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Boston Scientific | 4 | $74 |
| Verona Pharma, Inc. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $61 |
| Boehringer Ingelheim | 4 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Viatris Specialty LLC | 3 | $58 |
| Corcept Therapeutics | 3 | $52 |
| Lundbeck LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 1 | $38 |
| Merck | 2 | $34 |
| Dexcom, Inc. | 2 | $33 |
| Mylan Specialty L.p. | 2 | $32 |
| Tactile Systems Technology Inc | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Novartis | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| UCB, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Bayer | 1 | $13 |
How this compares
$2,531 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $21,208 |
| EliquisApixaban | 21 | $19,342 |
| RybelsusSemaglutide | 15 | $13,906 |
| JardianceEmpagliflozin | 15 | $9,388 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $778 |
| Gabapentin | 24 | $572 |
| Losartan Potassium | 40 | $511 |
| Atorvastatin Calcium | 39 | $504 |
| Rosuvastatin Calcium | 41 | $439 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 51 | $383 |
| Levothyroxine Sodium | 41 | $380 |
| Pantoprazole Sodium | 34 | $310 |
| Omeprazole | 21 | $310 |
| Metoprolol Succinate | 25 | $221 |
| Tramadol Hcl | 42 | $219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $199 | $21,20822 claims |
| PfizerEliquis | $196 | $19,34221 claims |
| Novo NordiskRybelsus | $251 | $13,90615 claims |
| Boehringer IngelheimJardiance | $61 | $9,38815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.
Other family in New Paris
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.